Newpath Partners, L.P. 13D and 13G filings for Prime Medicine, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:15 pm Purchase | 2024-12-31 | 13G | Prime Medicine, Inc. PRME | Newpath Partners, L.P. | 6,105,679 4.700% | 800,000 (+15.08%) | Filing |
| 2023-02-07 4:46 pm Purchase | 2022-12-31 | 13G | Prime Medicine, Inc. PRME | Newpath Partners, L.P. | 5,305,679 5.500% | 5,305,679 (New Position) | Filing |